Discover

'Entecavir' (INN) (IPA: ) is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name 'Baraclude' (BMS).
Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.

Contents

External links

External links

★ Baraclude U.S. website